Fansen Ji

684 total citations
5 papers, 226 citations indexed

About

Fansen Ji is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Fansen Ji has authored 5 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Fansen Ji's work include Cancer Immunotherapy and Biomarkers (2 papers), HIV Research and Treatment (1 paper) and Cancer-related Molecular Pathways (1 paper). Fansen Ji is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), HIV Research and Treatment (1 paper) and Cancer-related Molecular Pathways (1 paper). Fansen Ji collaborates with scholars based in China and United States. Fansen Ji's co-authors include Thomas A. Russo, Chao Liu, Pengcheng Du, Jun Guo, Xun Lan, Nan Xiao, Le Li, Peng Jiang, Longfei Deng and Pengbo Yao and has published in prestigious journals such as Nature Communications, Virulence and Nature Metabolism.

In The Last Decade

Fansen Ji

5 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fansen Ji China	4	96	80	55	40	38	5	226
Zhuo Cao China	12	175 1.8×	86 1.1×	76 1.4×	56 1.4×	30 0.8×	27	391
Verònica Alba Spain	12	79 0.8×	75 0.9×	61 1.1×	17 0.4×	27 0.7×	21	309
Chung-Ming Chang Taiwan	9	111 1.2×	75 0.9×	45 0.8×	11 0.3×	39 1.0×	10	357
Ning Song China	9	89 0.9×	96 1.2×	45 0.8×	61 1.5×	14 0.4×	20	325
Changting Liu China	12	192 2.0×	31 0.4×	53 1.0×	65 1.6×	32 0.8×	23	327
Yuqin Shen China	7	143 1.5×	43 0.5×	28 0.5×	48 1.2×	21 0.6×	15	279
Yuhong Dou China	9	118 1.2×	47 0.6×	111 2.0×	91 2.3×	18 0.5×	11	307
Joan Chen United States	6	140 1.5×	65 0.8×	27 0.5×	28 0.7×	15 0.4×	15	278
Yahong Zheng China	10	196 2.0×	37 0.5×	51 0.9×	57 1.4×	16 0.4×	16	402
Shuangquan Yan China	12	128 1.3×	43 0.5×	70 1.3×	42 1.1×	33 0.9×	27	363

Countries citing papers authored by Fansen Ji

Since Specialization

Citations

This map shows the geographic impact of Fansen Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fansen Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fansen Ji more than expected).

Fields of papers citing papers by Fansen Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fansen Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fansen Ji. The network helps show where Fansen Ji may publish in the future.

Co-authorship network of co-authors of Fansen Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Fansen Ji. A scholar is included among the top collaborators of Fansen Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fansen Ji. Fansen Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ji, Fansen, Weimin Bi, Jiawei Zhang, et al.. (2025). scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution. Clinical and Translational Discovery. 5(3). 2 indexed citations

2.

Pang, Huanhuan, Yisheng Jiang, Jie Li, et al.. (2021). Aberrant NAD+ metabolism underlies Zika virus–induced microcephaly. Nature Metabolism. 3(8). 1109–1124. 47 indexed citations

3.

Ji, Fansen, et al.. (2021). Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment. npj Precision Oncology. 5(1). 37–37. 4 indexed citations

4.

Deng, Longfei, Pengbo Yao, Le Li, et al.. (2020). p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival. Nature Communications. 11(1). 1755–1755. 87 indexed citations

5.

Liu, Chao, Pengcheng Du, Nan Xiao, et al.. (2020). Hypervirulent Klebsiella pneumoniae is emerging as an increasingly prevalent K. pneumoniae pathotype responsible for nosocomial and healthcare-associated infections in Beijing, China. Virulence. 11(1). 1215–1224. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact